160 related articles for article (PubMed ID: 26544088)
1. Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors.
Fazi R; Tintori C; Brai A; Botta L; Selvaraj M; Garbelli A; Maga G; Botta M
J Chem Inf Model; 2015 Nov; 55(11):2443-54. PubMed ID: 26544088
[TBL] [Abstract][Full Text] [Related]
2. Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: towards the next generation HIV-1 inhibitors.
Radi M; Falchi F; Garbelli A; Samuele A; Bernardo V; Paolucci S; Baldanti F; Schenone S; Manetti F; Maga G; Botta M
Bioorg Med Chem Lett; 2012 Mar; 22(5):2094-8. PubMed ID: 22300661
[TBL] [Abstract][Full Text] [Related]
3. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.
Brai A; Fazi R; Tintori C; Zamperini C; Bugli F; Sanguinetti M; Stigliano E; Esté J; Badia R; Franco S; Martinez MA; Martinez JP; Meyerhans A; Saladini F; Zazzi M; Garbelli A; Maga G; Botta M
Proc Natl Acad Sci U S A; 2016 May; 113(19):5388-93. PubMed ID: 27118832
[TBL] [Abstract][Full Text] [Related]
4. Targeting the human DEAD-box polypeptide 3 (DDX3) RNA helicase as a novel strategy to inhibit viral replication.
Garbelli A; Radi M; Falchi F; Beermann S; Zanoli S; Manetti F; Dietrich U; Botta M; Maga G
Curr Med Chem; 2011; 18(20):3015-27. PubMed ID: 21651478
[TBL] [Abstract][Full Text] [Related]
5. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
6. Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation.
Maga G; Falchi F; Radi M; Botta L; Casaluce G; Bernardini M; Irannejad H; Manetti F; Garbelli A; Samuele A; Zanoli S; Esté JA; Gonzalez E; Zucca E; Paolucci S; Baldanti F; De Rijck J; Debyser Z; Botta M
ChemMedChem; 2011 Aug; 6(8):1371-89. PubMed ID: 21698775
[TBL] [Abstract][Full Text] [Related]
7. The interaction of RNA helicase DDX3 with HIV-1 Rev-CRM1-RanGTP complex during the HIV replication cycle.
Mahboobi SH; Javanpour AA; Mofrad MR
PLoS One; 2015; 10(2):e0112969. PubMed ID: 25723178
[TBL] [Abstract][Full Text] [Related]
8. DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model.
Quaranta P; Lottini G; Chesi G; Contrafatto F; Russotto R; Macera L; Lai M; Spezia PG; Brai A; Botta M; Freer G; Pistello M
Antiviral Res; 2020 Jun; 178():104750. PubMed ID: 32205137
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3.
Maga G; Falchi F; Garbelli A; Belfiore A; Witvrouw M; Manetti F; Botta M
J Med Chem; 2008 Nov; 51(21):6635-8. PubMed ID: 18834110
[TBL] [Abstract][Full Text] [Related]
10. DDX3 DEAD-box RNA helicase is required for hepatitis C virus RNA replication.
Ariumi Y; Kuroki M; Abe K; Dansako H; Ikeda M; Wakita T; Kato N
J Virol; 2007 Dec; 81(24):13922-6. PubMed ID: 17855521
[TBL] [Abstract][Full Text] [Related]
11. Analog sensitive chemical inhibition of the DEAD-box protein DDX3.
Floor SN; Barkovich KJ; Condon KJ; Shokat KM; Doudna JA
Protein Sci; 2016 Mar; 25(3):638-49. PubMed ID: 26650549
[TBL] [Abstract][Full Text] [Related]
12. RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity.
Valiente-Echeverría F; Hermoso MA; Soto-Rifo R
Rev Med Virol; 2015 Sep; 25(5):286-99. PubMed ID: 26174373
[TBL] [Abstract][Full Text] [Related]
13. The role of the DEAD-box RNA helicase DDX3 in mRNA metabolism.
Soto-Rifo R; Ohlmann T
Wiley Interdiscip Rev RNA; 2013; 4(4):369-85. PubMed ID: 23606618
[TBL] [Abstract][Full Text] [Related]
14. A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication.
Garbelli A; Beermann S; Di Cicco G; Dietrich U; Maga G
PLoS One; 2011 May; 6(5):e19810. PubMed ID: 21589879
[TBL] [Abstract][Full Text] [Related]
15. The Ded1/DDX3 subfamily of DEAD-box RNA helicases.
Sharma D; Jankowsky E
Crit Rev Biochem Mol Biol; 2014; 49(4):343-60. PubMed ID: 25039764
[TBL] [Abstract][Full Text] [Related]
16. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation.
Schröder M
Biochem Pharmacol; 2010 Feb; 79(3):297-306. PubMed ID: 19782656
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological inhibition of DEAD-Box RNA Helicase 3 attenuates stress granule assembly.
Cui BC; Sikirzhytski V; Aksenova M; Lucius MD; Levon GH; Mack ZT; Pollack C; Odhiambo D; Broude E; Lizarraga SB; Wyatt MD; Shtutman M
Biochem Pharmacol; 2020 Dec; 182():114280. PubMed ID: 33049245
[TBL] [Abstract][Full Text] [Related]
18. Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses.
Riva V; Garbelli A; Brai A; Casiraghi F; Fazi R; Trivisani CI; Boccuto A; Saladini F; Vicenti I; Martelli F; Zazzi M; Giannecchini S; Dreassi E; Botta M; Maga G
J Med Chem; 2020 Sep; 63(17):9876-9887. PubMed ID: 32787106
[TBL] [Abstract][Full Text] [Related]
19. Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays.
Nakao S; Nogami M; Iwatani M; Imaeda T; Ito M; Tanaka T; Tawada M; Endo S; Cary DR; Ohori M; Imaeda Y; Kawamoto T; Aparicio S; Nakanishi A; Araki S
Biochem Biophys Res Commun; 2020 Mar; 523(3):795-801. PubMed ID: 31954521
[TBL] [Abstract][Full Text] [Related]
20. Viruses and the human DEAD-box helicase DDX3: inhibition or exploitation?
Schröder M
Biochem Soc Trans; 2011 Apr; 39(2):679-83. PubMed ID: 21428961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
